Midwest Eye Consultants, P.C. – Trademark Portfolio
Entity Type: 57
Midwest Eye Consultants, P.C. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EMAGE VISION CENTER and INDIANA LASIK CENTERS. The owner is based in Wabash, IN.
835 N. Cass St.
Wabash, IN 46992
Showing of trademarks Trademarks
Trademark Classifications
Midwest Eye Consultants, P.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Midwest Eye Consultants, P.C. have?
Midwest Eye Consultants, P.C. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Midwest Eye Consultants, P.C. file in?
Midwest Eye Consultants, P.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Midwest Eye Consultants, P.C.'s most well-known trademarks?
Midwest Eye Consultants, P.C.'s registered trademark portfolio includes well-known marks such as EMAGE VISION CENTER and INDIANA LASIK CENTERS. These are among 2 currently registered trademarks in the portfolio.
What is Midwest Eye Consultants, P.C.'s trademark registration success rate?
Midwest Eye Consultants, P.C. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.